Journal List > Korean J Gastroenterol > v.58(1) > 1006901

Chun, Chang, Lee, Lee, Chung, Jung, Choi, and Chung: Steroid Responsive Pancreatic Mass-Forming Type 2 Autoimmune Pancreatitis

Abstract

Autoimmune pancreatitis (AIP) has two distinct subsets. Type 1 AIP or lymphoplasmacytic sclerosing pancreatitis is systemic disease with the elevation in serum levels of the IgG4. Type 2 AIP, also called duct-centric pancreatitis, features granulocyte epithelial lesions with duct obstruction in the pancreas without systemic involvement. Here, we report a case of type 2 AIP diagnosed by pathology, which is the first report in Korea. The case is a 56-year-old woman who presented with anorexia and vomiting. Computed tomography revealed mass-like lesion in the pancreatic head and the compression of the distal common bile duct and the head portion of the main pancreatic duct. Serum levels of the IgG4 were normal. Histologic examination revealed a dense neutrophil infiltration in the pancreatic parenchyme associated with extensive fibrosis, thereby confirming the diagnosis of type 2 AIP. The abnormalities in the clinical, laboratory, and radiological findings improved after oral steroid treatment.

References

1. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas–an autonomous pancreatic disease? Am J Dig Dis. 1961; 6:688–698.
crossref
2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995; 40:1561–1568.
3. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut. 2009; 58:1680–1689.
crossref
4. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut. 2002; 51:1–4.
crossref
5. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001; 344:732–738.
crossref
6. Ectors N, Maillet B, Aerts R, et al. Nonalcoholic duct destructive chronic pancreatitis. Gut. 1997; 41:263–268.
crossref
7. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol. 2003; 27:1119–1127.
8. Klöppel G. Chronic pancreatitis, pseudotumors and other tumor-like lesions. Mod Pathol. 2007; 20(Suppl 1):S113–S131.
crossref
9. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007; 20:23–28.
crossref
10. Kim KP, Kim M, Lee YJ, et al. Clinical characteristics of 17 cases of autoimmune chronic pancreatitis. Korean J Gastroenterol. 2004; 43:112–119.
11. Kim JY, Chang HS, Kim MH, et al. A case of autoimmune chronic pancreatitis improved with oral steroid therapy. Korean J Gastroenterol. 2002; 39:304–308.
12. Park SJ, Kim MH, Moon SH, et al. Clinical characteristics, recurrence features, and treatment outcomes of 55 patients with autoimmune pancreatitis. Korean J Gastroenterol. 2008; 52:230–246.
13. Lee JY, Park DH, Park SH, et al. Two cases of seronegative, main pancreatic ductal narrowing, chronic pancreatitis that were responsive to short-term steroid treatment. Korean J Med. 2007; 72(Suppl 2):S103–S109.
14. Zamboni G, Lüttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch. 2004; 445:552–563.
crossref
15. Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immuno-logical features. Pancreas. 2003; 27:14–19.
crossref
16. Yadav D, Notahara K, Smyrk TC, et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology, and natural history after resection. Clin Gastroenterol Hepatol. 2003; 1:129–135.
crossref
17. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol. 2003; 98:2811–2812.
crossref
18. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology. 2007; 242:791–801.
crossref
19. Okazaki K, Kawa S, Kamisawa T, et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas. 2009; 38:849–866.
20. Detlefsen S, Mohr Drewes A, Vyberg M, Klöppel G. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch. 2009; 454:531–539.
crossref

Fig. 1.
Abdominal CT and MRI/MRCP findings. (A) Abdominal CT showed bulging contour, mass-like lesion in the head of the pancreas (arrow). (B, C) Pancreas and bile duct MRI/MRCP showed diffuse swelling of the pancreas head and compression of the distal common bile duct and proximal pancreatic duct, resulting in dilatation of the extrahepatic bile duct and pancreatic duct (arrows).
kjg-58-53f1.tif
Fig. 2.
Pathological findings. (A) Biopsy showed focal fibrosis and parenchymal destruction of pancreas (H&E stain, ×100). (B) Higher magnification showed diffuse infiltration of neutrophils in the parenchyme of the pancreas (arrow) in the epithelial cells of the ductule (circle)(H&E stain,×400). L, lumen.
kjg-58-53f2.tif
Fig. 3.
Abdominal CT findings. (A) Follow up CT scan after 15 days from the start of prednisolone. Globular swelling of the pancreas head decreased comparing with Fig. 1A. (B) Follow up CT scan after 2 and half months from the start of predni-solone showed marked decrease of pancreas swelling.
kjg-58-53f3.tif
TOOLS
Similar articles